Neuroone Medical Technologies Corp
NMTC- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001500198
In the last 90 days, Neuroone Medical Technologies Corp insiders filed 1 open-market purchase and 1 sale; 26 institutions reported holding it in 13F filings for Q2 2026, worth $6.21M in total; no superinvestor holds it.
13F holders, Q2 2024
Institutional positions in Neuroone Medical Technologies Corp as of Jun 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 19
- 0 vs. Q1 2024
- Shares held
- 3.69M
- −611.5K (−14.2%) vs. Q1 2024
- Total value
- $2.95M
- −$2.21M (−42.8%) vs. Q1 2024
- New holders
- 4
- 7 more added
- Sold out
- 4
- 2 more reduced
Compare with Q1 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting NMTC on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 26 | $6.21M |
| Q1 2026 | 32 | $9.14M |
| Q4 2025 | 37 | $9.44M |
| Q3 2025 | 34 | $12.8M |
| Q2 2025 | 31 | $9.80M |
| Q1 2025 | 19 | $2.63M |
| Q4 2024 | 21 | $2.30M |
| Q3 2024 | 22 | $3.59M |
| Q2 2024 | 19 | $2.95M |
| Q1 2024 | 19 | $5.16M |
| Q4 2023 | 21 | $6.81M |
| Q3 2023 | 20 | $3.71M |
| Q2 2023 | 15 | $1.79M |
| Q1 2023 | 16 | $2.44M |
| Q4 2022 | 21 | $1.53M |
| Q3 2022 | 12 | $2.99M |
| Q2 2022 | 11 | $1.51M |
| Q1 2022 | 12 | $2.33M |
| Q4 2021 | 17 | $6.52M |
| Q3 2021 | 9 | $4.94M |
| Q2 2021 | 4 | $9.36M |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2024
Shares, value and share of portfolio for each institution holding Neuroone Medical Technologies Corp; share changes are against Q1 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Nantahala Capital Management, LLC | 950,962 | $760.8K | 0.08% | −247,950−20.7% | Reduced |
| AWM Investment Company, Inc. | 950,000 | $760.0K | 0.10% | −500,000−34.5% | Reduced |
| Vanguard Group Inc | 919,528 | $735.6K | 0.00% | +2070.0% | Added |
| Geode Capital Management, LLC | 258,883 | $207.2K | 0.00% | +36,934+16.6% | Added |
| Mayo Clinic | 181,754 | $145.4K | 4.80% | 00.0% | Unchanged |
| Perkins Capital Management Inc | 150,000 | $120.0K | 0.11% | 00.0% | Unchanged |
| State Street Corp | 59,499 | $47.6K | 0.00% | +7,900+15.3% | Added |
| UBS Group AG | 57,303 | $45.8K | 0.00% | +57,195+52,958.3% | Added |
| MAI Capital Management | 50,000 | $40.0K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 30,281 | $24.2K | 0.00% | 00.0% | Unchanged |
| Virtu Financial LLC | 19,149 | $15.0K | 0.00% | +19,149 | New |
| Raymond James & Associates | 17,400 | $13.9K | 0.00% | +17,400 | New |
| Princeton Global Asset Management LLC | 16,833 | $13.5K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 11,403 | $9.12K | 0.00% | +4,401+62.9% | Added |
| Cambridge Investment Research Advisors, Inc. | 10,400 | $8.00K | 0.00% | +10,400 | New |
| Advisor Group Holdings, Inc. | 1,259 | $1.01K | 0.00% | +909+259.7% | Added |
| Nemes Rush Group LLC | 433 | $346 | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 216 | $173 | 0.00% | +216 | New |
| JPMorgan Chase & Co | 57 | $46 | 0.00% | +2+3.6% | Added |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −11,310−100.0% | Sold out |
| Centerpoint Advisors, LLC | 0 | $0 | 0.00% | −5,000−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −1,720−100.0% | Sold out |
| Wells Fargo & Company | 0 | $0 | 0.00% | −193−100.0% | Sold out |